Elmiron (pentosane polysulfate sodium), a drug prescribed to treat interstitial cystitis (IC), has been linked to maculopathy, an eye disorder that can lead to loss of vision and complete blindness. Lawsuits are mounting against Janssen Pharmaceuticals, the maker of the medication, alleging that the company failed to warn patients about the risk of vision problems and the need for regular eye exams.
If you or a family member have taken Elmiron and have suffered from these serious side effects, call Gersowitz Libo & Korek, P.C. for a free consultation to discuss the details of your case. You may be entitled to compensation for the life altering changes caused by vision loss and blindness.
Dangers Associated with Elmiron Comet to Light
The potential risks associated with Elmiron were unknown until 2015, when doctors at Atlanta’s Emory Eye Center came across an eye disorder they had never encountered in six women. This type of maculopathy did not seem to have a root cause, but additional investigation revealed that all six women had been taking Elmiron for years.
More studies were released in 2018 and 2019 supporting the link between Elmiron and this eye disorder. It still unknown how Elmiron causes this disorder.
Common symptoms of the specific form of Maculopathy linked to Elmiron include:
- A change in the color of the retina itself
- Dark spots in visions
- Straight lines turned curved or squiggly
- Muted, less vivid colors
- Trouble reading
- Blurred vision, including in the center of the field of view
- A hard time adjusting to dimmer lighting
It also appears that damage to the retina can continue to occur even after a patient stops taking Elmiron.
Lawsuits are mounting against Janssen Pharmaceuticals, alleging that the company failed to warn patients about the risk of vision problems and the need for regular eye exams.
Due to increasing reports in the literature of this specific retinal damage, in June 2020 the Elmiron label was updated to include a warning regarding retinal pigmentary changes identified with long-term use of Elmiron and to recommend continuous monitoring both during and after treatment.
Gersowitz Libo & Korerk, P.C. is currently investigating Elmiron cases. The claims against the company for damages caused by Elmiron are not class-action lawsuits. We bring each claim separately, although most of the suits are joining into a multidistrict litigation (MDL), which will expedite the negotiation and settlement process.
Contact an Elmiron Lawsuit Lawyer Today!
If you or a loved one has developed maculopathy eye damage after taking Elmiron, you may be entitled to compensation. The statute of limitations to file a claim is short. In most states, you only have one or two years to seek justice. So, victims should consult an attorney right away.
For more information or to schedule a complimentary consultation with a New York Elmiron lawsuit attorney today, please call Gersowitz Libo & Korek, P.C. at 1-646-798-1535.